Another investigation elucidated that exosomal miR-155 and miR-1246 were the principal overexpressed miRNAs in HER2-positive BC with TZB resistance, suggesting a remarkable prognostic value for these miRNAs (Zhang et al., 2020). The gene discussed is ERBB2; the disease is breast cancer.